Latest Health News

Tag: novartis

  • Novartis CEO plays down prospects for Actelion bid: Blick

    —

    by

    elegant
    in

    Novartis Chief Executive Joe Jimenez has played down suggestions the Swiss drugmaker could bid for Swiss biotech group Actelion, which is in talks with U.S. healthcare group Johnson & Johnson about a transaction. Asked by Swiss Sunday newspaper SonntagsBlick whether Novartis could emerge as a white knight, he said: “We have always said that we…

  • Novartis says 82 percent of leukemia patients in remission after CAR-T

    —

    by

    elegant
    in

    An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form of blood cancer in 82 percent of children and young adults treated with modified immune cells in a mid-stage trial, the company said on Saturday. Interim results from the multi-center trial for 50 patients with acute lymphoblastic leukemia whose cancer returned or…

  • FDA panel supports Novartis version of Amgen arthritis drug

    —

    by

    creative
    in

    Novartis AG's cheaper version of Amgen Inc's arthritis drug Enbrel is highly similar in potency and safety to the original and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday. The panel voted 20-O that there is no clinically meaningful difference between Novartis's drug, a biologic made of…

  • U.S. sends 47 troops to South Sudan to protect Americans

    —

    by

    publisher
    in

    The White House said on Wednesday that it had deployed 47 troops to South Sudan to protect U.S. citizens and the U.S. embassy after an outbreak of deadly violence in the country. “These deployed personnel will remain in South Sudan until the security situation becomes such that their presence is no longer needed,” the White…

  • Magnesium may modestly lower blood pressure

    —

    by

    publisher
    in

    By Kathryn Doyle (Reuters Health) – Magnesium supplements taken daily for three months may result in slightly lower blood pressure, according to an analysis of more than 30 existing studies. Previous evidence has suggested that magnesium deficiency may be related to cardiometabolic disorders, including high blood pressure, said lead author Yiqing Song. “Taking oral magnesium…

  • Novartis trial shows drug improves survival for AML patients

    —

    by

    elegant
    in

    ZURICH (Reuters) – Novartis' phase III study for its acute myeloid leukemia (AML) drug showed it improved overall survival by 23 percent for patients with FLT3 mutations, the Swiss drugmaker said on Sunday. Basel-based Novartis said the study was the first large controlled trial to show overall survival benefit in FLT3-mutated AML, and that worldwide…